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The Nevoid Basal-Cell Carcinoma Syndrome (NBCC), or as it is also referred to, basal-cell nevus syndrome or Gorlin-Goltz syn-
drome, is characterized by multiple early-appearing basal cell carcinomas, keratocytosis of the mandible, and anomalies of the
ocular, skeletal reproductive system. We describe four patients in the same family, all of them possessing a large number of skin
tumors associated with other typical clinical and X-Ray anomalies of NBCC. The definitive treatment of NBCC has yet to be estab-
lished, however, early diagnosis is very important as well as the periodical follow-up examination of ten patients, mainly due to the
transformations in the skin lesions that may occur.
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INTRODUCTION
The first historical evidence regarding the syndromegoes back to the 11th Egyptian dynasty. The firstcase of skin manifestation of the nevoid basal-cell
carcinoma syndrome or the Gorlin-Goltz syndrome was
described by Jarisch and White in 1894 (10,19). Although
only in the middle of this century the clinical findings of
the syndrome were systematized by Gorlin and Goltz (4).
The syndrome presents a dominant autosomal
transmission (2,12) and one third of the patients do not
have previous family history thus suggesting mutation or
incomplete penetration of the gene (5).
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Howell and Anderson (7) estimated a penetration of
the gene in approximately 97% of the cases and close to
75% of the individuals with NBCC represented premature
emergence of multiple basal-cell carcinomas.
The characterization of the gene which causes the
syndrome may help with the understanding of pathogenesis
of other basal-cell carcinomas. In addition the analysis of
the genetic heritage demonstrated that the gene is located
in chromosome 9q22.3-q31. The location of the gene offers
the possibility that the DNA markers should be used in
the evaluation of the survival of these patients as well as
allowing the diagnosis patients that have been diagnosed
with early symptoms.
The minimum prevalence is one 'in every 57,000
although 1 in every 200 patients with basal-cell carcinoma
present NBCC and the proportion is much larger with
patients that develop basal-cellular carcinoma before the
age of 19 (15,1). An enzyme defect may be responsible
for the development ofNBCC because these abnormalities
are multi-systemic.
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i=igur~ 1: Characteristic lesions of NBCC in the dorsal centerline, most of them being
pigmented basal-cell carcinomas.
The genetic studies suggest that the control of cellular
gro\y~h is the main function of the gene involved with
NBCC.
Also there is the possibility of the transforma-
tion of baso-cellular tumors into epidermoid carci-
nomas and melanoma.
The major clinical manifestations involve the
appearance of multiple basal-cell carcinomas, kera-
tocysts of the jaw and skeletal abnormalities espe-
cially in the ribs and vertebrae.
The clinical findings involve multiple systems.
Typical facial characteristics are found in up to 70% of
the cases consisting of an increase in the occipitofrontal
circumference, moderate-hypertelorium, merging of the
brows, and an excessive development of the superior
orbital ring. Other than the cited tumors, at the skin level
one finds keratosis on the soles and palms 65% of the
cases characterized by punctiform and asymetrical.
Miliaria, sebaceous cysts and epidermic cysts have also
been described.
The bone abnormalities of the ribs, such as its fusion,
spina bifida, cervical rib, sacralization of the lumbar
vertebrae spinal, deviations such, the presence of pectus
excavatum, or carinatum and hamartoma are among the
most frequent findings.
Calcified cysts, fibroma and
fibrosarcona of the ovaries are also
described. Calcifications of the
falxes cerebri and the tentorium
cerebelli hiperpneumatization of
the paranasal sinuses and
strabismus in higher numbers of
cases (5) (table 1).
CASE REPORT
Table 1 describes the main
findings on of the four patients,
all belonging to the same amily.
We want to call attention to the
large number of basal-cell
carcinomas found in every
member and, others that ..arose
during follow up.
Table I
Major diagnostic findings in adults with Nevoid
Basal-Cell Syndrome
(Naldi et aI., Arch Dermatol, 1991 )(16).
Typical facial characteristics
Marfan-like aspect
Multiple basal-cell carcinomas
Plantar and palmar keratosis
Miliaria and epidermal cysts
Odontogenic cysts of the mandible
Calcification of soft tissues
(especially falx cerebris) falx cerebris
Bone abnormalities
Rib or bifide fusion
Vertebrae - kifoscoliosis or to spina bifide
Pectus carinatum or excavatum
Snort fourth metacarp
Polydactily or sindactily
Mesenteric cysts
Ocular abnomalities
Congenital cataract, glaucoma, iris coloboma
Tumors
Medulloblastoma, meningeoma, fetal
rabdomyoma, cardiac fibroma, ovarian
fibrosarcoma
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Table II
Name Gender Age years Number of Lesion Pathologic Associated
lesions evolution* anatomy and manifestations
number of
lesions
EAV (fig.1) F 55 32 B.C.C.** Typical facial
characteristics
Epidermoide cysts
Ovarian fibrome
Calcification of the
falx
Mandibular cyst
Sacralization of
L5
Kiphoscoliosis
JDV (fig.2) M 32 9 10 B.C.C. - 15 Typical facial
Solid epithelioma characteristics
-2 Lumbar scoliosis
Nevocellular Hyperteleorbitism
nevus - 1 Sacralization of
L5
Mandibular cyst
AMV F 29 6 B.C.C - 5 Typical facial
Melanocytic characteristics
nevus - 5 Erosion of the
sella tursica
ALV (fig.3) M 20 7 2 B.C.C -7 Typical facial
Nevocellular characteristics
nevus - 1 Mandibular cyst
Microinvasive
8.C.C. - 1
Lesion Evolution - Number of lesions that appeared during patient's follow-up
S.C.C. - Basal-Cell Carcinoma
Among the single basal-cell tumors, the percentage
of solid tumors is high (88.9%). According to the results
of McKnight et al. (15); Maddox (13); and a study by
Jackson and Gardere (9), the frequency of the different
subtypes of basal-cell tumors found in patients with NBCC
(is solid type 72%, cystic 19%, sclerodermiform 17%,
adenoid 27%, and superficial 6%). Approximately one
third of the patients show two or more types of tumors.
Mason discovered in 1965 (14) that out of the 370 tumors
examined, 11 presented osteoids or associated bone tissue.
This study showed that it is not possible to diagnose NBCC
based on histologic examination solely.
NBCC is a good study model for oncogenesis,
particularly the interaction between environmental and
genetic factors.
Many findings suggest that the primary function of
the gene is the control of cellular growth. The pattern of
multisystemic malformations presented suggest that its
activity influences the three germinative tissues of the
embryo (2).
TINCANI, A.J., ANDRADE, R.G., FRANCO JR, E.F.M., CAMARGO, MAB. & MARTINS, A.S. -
Nevoid Basal-Cell Syndrome: literature review and case report in a family
sao Paulo Medical Journal/RPM 113(3): 917-921,1995
920
Figure 2: The arrow shows calcification areas in the falx cerebri
Biochemical studies try to characterize the
association of the excessive prostaglandin level with the
aggressive growth of the basal-cell carcinomas, as well
as with its effect on the bone reabsorption present at the
formation of odontogenic cysts of the jaw (6,18).
. The differential diagnosis of NBCC must be made
with the Bazex Syndrome, Rombo Syndrome, and the
Rasmussen Syndrome (5). The present of a large cranial
circumference and vertebral or rib abnormalities in
children without a family history should be an indication
for further investigations.
The variety of clinical signs constitute a diagnostic
problem. Some of these signs are seen in less than 10%
of the described cases, and there are a number of possible
associations (medulloblastoma, meningioma, metacarpus
brevis, palate and labium fissure, congenital cataract,
glaucoma, coloboma, fibroma, etc.) (5).
Figure 3: Cysts in the mandibular arch (arrows)
In view of the frequent pathologic skin
modifications, the follow-up of patients every 3 to 6
months is required particularly between puberty and the
age of 35, mainly because of the possible appearance
of epidermoid carcinoma and cutaneous melanoma at
the lesions. Special attention must be given to lesions
located near the natural orifices (ears, eyes, nose) due
to their potential destruction by the invasion of the
tumors.
The treatment in most cases is the surgical
removal of the lesion because of its well known
aggress.ive evolution. In some cases of small lesions
treatment can be cryosurgery and elec-
trocauterization, as well as curettage (16). The real
value of topical immunotherapy and the use of 5-
fluoracil are under study. The use of 13-cis-retinoic
acid taken orally and in high dosages seems to be
effective in the prevention of tumor appearances, as
well as in the reduction of the growth rate of old
lesions (16).
The complete removal of the mandibular cysts
is necessary due to the high rate of relapse (4).
The association with radiotherapy in the
treatment may not be advisable, due to the fact that
the exposure to radiation stimulates the appearance
of new lesions and that it requires large areas to be
irradiated. The association between NBCC and
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medulloblastoma has been firmly established by the
appearance of the tumor in 20% of patients with
NBCC. Patients with NBCC and medulloblastoma and
treated with radiotherapy have shown a higher rate of
sarcomatous transformation of ovarian fibromas as
well as the appearance of a large number of skin
tumors at the site where the radiotherapy was applied
(1 ).
In literature there are descriptions of NBCC cases
in families of many different ethnic backgrounds
(3,11,17).
CONCLUSIONS
NBCC is a rare entity and little is known regarding
its physiopathology. A precise and early diagnosis is of
utmost importance in order to improve the approach to
skin lesions, thus avoiding their consequences.
Solar protection is important for all patients and a
periodic follow-up in addition to genetic counseling is
necessary.
RESUMO
Introdu~ao: A Sfndrome do Nevo Basocelular (SNBC), tambem chamada de Sfndrome do Carcinoma Nev6ide Basocelular
ou Sfndrome de Gorlin-Goltz, caracteriza-se por multiplos carcinomas basocelulares de aparecimento precoce, cistos em
mandfbula, alem de outras anomalias como as 6sseas, problemas oculares e no aparelho reprodutivo. Conclusao: 0 tratamento
definitivo da SNBC ainda nao foi bem estabelecido, porem ressalta-se a import€mcia do diagn6stico precoce, alem do seguimento
peri6dico dos pacientes, principalmente devido as transforma90es das lesoes da pele que podem ocorrer.
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